Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183456 · ClinicalTrials.gov registry record · Phase 2
A Peer-Oriented HIV Prevention Outreach Program for Individuals at High Risk for HIV and Other STIs
A Phase 2 study of HIV Infections and Sexually Transmitted Diseases, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 746
- Enrollment target
- 1
- Study location
NCT00183456 is a Phase 2 study of HIV Infections and Sexually Transmitted Diseases that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 746 participants, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (68% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00183456, a Phase 2 study of HIV Infections and Sexually Transmitted Diseases, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 746 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine the effectiveness of a peer outreach intervention in preventing HIV infection in adults at high risk for contracting HIV and other sexually transmitted diseases (STDs).
Conditions Studied
Interventions
- BEHAVIORAL Peer-oriented intervention
- BEHAVIORAL Group cognitive behavioral therapy (CBT)
Study Locations (1)
Maryland
- The Lighthouse - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 746 participants |
| Start Date | 2005-09 |
| Est. Completion | 2009-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00183456
The ClinicalTrials.gov registry entry for NCT00183456 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 746 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (68% higher). The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Peer-oriented intervention is the first listed.
NCT00183456 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00183456 about?
NCT00183456 is a clinical study titled "A Peer-Oriented HIV Prevention Outreach Program for Individuals at High Risk for HIV and Other STIs". This study will determine the effectiveness of a peer outreach intervention in preventing HIV infection in adults at high risk for contracting HIV and other sexually transmitted diseases (STDs).
What is the current status of trial NCT00183456?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 746 participants. The study started on 2005-09. Estimated completion is 2009-12.
What conditions does trial NCT00183456 study?
This clinical trial studies the following conditions: HIV Infections, Sexually Transmitted Diseases.
What interventions are being tested in trial NCT00183456?
The interventions under investigation include: Peer-oriented intervention (BEHAVIORAL), Group cognitive behavioral therapy (CBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00183456?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00183456 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
RECRUITING · Phase 2
-
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
RECRUITING · Phase 2
-
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
RECRUITING · Phase 2
-
Imaging Immune Activation in HIV by PET-MR
RECRUITING · Phase 2
-
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M)
ACTIVE NOT RECRUITING · Phase 2
-
A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.